Optimizing the clinical identification and management of patients at risk for anaphylaxis

Journal of Family Practice

Volumn 59, Issue 8, 2010, Pages

  Stoloff, Stuart W ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLAXIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; HUMAN; REVIEW; DIFFERENTIAL DIAGNOSIS; HYPOTENSION; MASS SCREENING; PROCEDURES; RISK FACTOR; SECONDARY PREVENTION; TIME;

ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOTENSION; MASS SCREENING; RECURRENCE; RISK FACTORS; TIME FACTORS; SECONDARY PREVENTION;

EID: 77956066916     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol. 2010;125:1098-1104.e1.
2. Simons FE. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol. 2009;124:625-636.
3. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391-397.
4. Lieberman P, Kemp SF, Oppenheimer J, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115(suppl 2):S483-S523.
5. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;125(2 suppl 2): S161-S181.
6. Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97:596-602.
7. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. 2009;124:1549-1555.
8. Decker WW, Campbell RL, Manivannan V, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol. 2008;122:1161-1165.
9. Matasar MJ, Neugut AI. Epidemiology of anaphylaxis in the United States. Curr Allergy Asthma Rep. 2003;3:30-35.
10. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol. 2005;115:575-583.
11. National Institute of Allergy and Infectious Diseases. Guidelines for the diagnosis and management of food allergy. Available at: www.niaid.nih.gov/ topics/foodAllergy/clinical/Documents/guidelines.pdf. Accessed June 30, 2010.
12. Chapman JA, Bernstein IL, Lee RE, et al. Food allergy: a practice parameter. Ann Allergy Asthma Immunol. 2006;96:S1-S68.
13. Moffitt JE, Golden DBK, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update. J Allergy Clin Immunol. 2004;114:869-886.
14. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006;117:367-377.
15. Munoz-Furlong A, Weiss C. Characteristics of food-allergic patients placing them at risk for a fatal anaphylactic episode. Curr Allergy Asthma Rep. 2009;9:57-63.
16. Muraro A, Roberts G, Simons FER. New visions for anaphylaxis: an iPAC summary and future trends. Pediatr Allergy Immunol. 2008;19:40-50.
17. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007;98:252-257.
18. Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007;120(1 suppl): S2-S24.
19. Pieretti MM, Chung D, Pacenza R, et al. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol. 2009;124:337-341.
20. Boyano-Martinez T, Garcia-Ara C, Pedrosa M, et al. Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol. 2009;123:883-888.
21. Kemp SF, Lockey RF, Simons FE; World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008;63:1061-1070.
22. Rudders SA, Banerji A, Corel B, et al. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics. 2010;125:e711-e718.
23. Manivannan V, Campbell RL, Bellolio MF, et al. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol. 2009;103:395-400.
24. Jarvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol. 2008;122:133-138.
25. Simons FE, Edwards ES, Read EJ Jr, et al. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol. 2010;125:419-423.e4.
26. Arkwright PD, Farragher AJ. Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children. Pediatr Allergy Immunol. 2006,17:227-229.
27. Kim JS, Sinacore JM, Pongracic JM. Parental use of EpiPen for children with food allergies. J Allergy Clin Immunol. 2005;116:164-168.
28. EpiPen [package insert]. Napa, CA: Dey Pharma, LP; April 2009. Available at: www.epipen.com/files/Legacy-Physician-Insert.pdf. Accessed June 30, 2010.
29. Twinject [package insert]. Atlanta, GA: Shionogi Pharma, Inc; January 2010. Available at: www.twinject.com/dovmloads/Twinject-Prescribing-Information. pdf. Accessed June 30, 2010.
30. Adrenaclick [package insert]. Atlanta, GA: Sciele Pharma, Inc; October 2009. Available at: http://adrenaclick.com/assets/Adrenaclick-Pl.pdf. Accessed June 30, 2010.
31. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007;62:830-837. (Pubitemid 47037864)
32. Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203-2217.
33. Sicherer SH, Simons FE; Section on Allergy and Immunology, American Academy of Pediatrics. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics. 2007;119:638-646.